Dyalfa®

Dyalfa®

Therapeutic Segment: Vitamin

Generic Name: Alfacalcidol

Indications:

It is indicated in all conditions where there is a disturbance of calcium metabolism due to impaired 1-α hydroxylation such as when there is reduced renal function. The main indications are:
-Renal osteodystrophy
-Hyperparathyroidism (with bone disease)
-Hypoparathyroidism
-Neonatal hypocalcaemia
-Nutritional and malabsorptive rickets and osteomalacia
-Pseudo-deficiency (D-dependent) rickets and osteomalacia
-Hypophosphataemic vitamin D resistant rickets and osteomalacia

Available as:                                                              PRESCRIBING INFORMATION

Tablets
  • 0.25 mcg
  • 0.5 mcg
  • 1 mcg